Literature DB >> 19267257

A rare surgical case of multiple liver resections for recurrent liver metastases from pancreatic gastrinoma: liver and vena cava resection.

Silvia Pachera1, Yukihiro Yokoyama, Hideki Nishio, Koji Oda, Tomoki Ebata, Tsuyoshi Igami, Tetsuya Abe, Yuji Shingu, Masato Nagino.   

Abstract

Pancreatic gastrinoma is a rare non-beta islet cell tumor. Approximately 60% of gastrinomas are malignant; despite the fact that they are usually slow growing, liver metastases have a major impact on prognosis. Most authors have advocated aggressive surgical management as being the only potentially curative therapy to improve survival as well as to provide outstanding relief from symptoms. We present a case of a 57-year-old man referred to our hospital with a diagnosis of liver metastases from pancreatic gastrinoma, with suspected involvement of the inferior vena cava (IVC). At the age of 37 years, he was diagnosed in his local hospital as having a pancreatic gastrinoma, with liver metastases, and he underwent distal pancreatectomy, splenectomy and enucleation of liver metastases. A liver tumor recurred twice, 7 and 9 years after the first surgery, for which double liver resections were performed: the first time he underwent enucleation of multiple liver metastases in segments II, III, IV, V, VI, VII and VIII, with resection of the right hepatic vein and partially resection of the diaphragm; the second time he underwent enucleation of multiple liver metastases in segments II, III, IV, and V. In our hospital, 8 years after the last surgery, the patient underwent right extended trisectionectomy, resection of segment I, combined resection of the IVC, and partial removal of the diaphragm. To the best of our knowledge, from a review of the literature, this is the first case to achieve successful long-term survival through aggressive surgical management of this type of metastatic endocrine tumor. The patient described here is still alive, free of disease and leading a normal life, 20 years after the initial diagnosis and 3 years after the last surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19267257     DOI: 10.1007/s00534-009-0055-0

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  3 in total

Review 1.  Zollinger-Ellison syndrome: classical considerations and current controversies.

Authors:  Irene Epelboym; Haggi Mazeh
Journal:  Oncologist       Date:  2013-12-06

2.  Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection.

Authors:  Jeffrey A Norton; Edmund J Harris; Yijun Chen; Brendan C Visser; George A Poultsides; Pamela C Kunz; George A Fisher; Robert T Jensen
Journal:  Arch Surg       Date:  2011-06

3.  Misdiagnosed gastrinoma: A case report.

Authors:  Qi-Kai Sun; Wei Wang; Hang-Cheng Zhou; Yang Lv; Ji-Hai Yu; Jin-Liang Ma; Wei-Dong Jia; Ge-Liang Xu
Journal:  Oncol Lett       Date:  2014-04-01       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.